Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports - Reuters

Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports  Reuters

Pfizer closes in on $7.3bn takeover of anti-obesity drugmaker Metsera - Financial Times

Pfizer closes in on $7.3bn takeover of anti-obesity drugmaker Metsera  Financial Times

Pfizer Near Potential $7.3 Billion Metsera Takeover, FT Says - Bloomberg.com

Pfizer Near Potential $7.3 Billion Metsera Takeover, FT Says  Bloomberg.com

Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports - Yahoo F...

Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports  Yahoo Finance

Pfizer nears $7.3B takeover of weight loss drugmaker Metsera, FT reports (PFE:NYSE) - Seeking Alpha

Pfizer nears $7.3B takeover of weight loss drugmaker Metsera, FT reports (PFE:NYSE)  Seeking Alpha

Pfizer close to $7.3 bln takeover of weight loss drugmaker Metsera- FT - Investing.com

Pfizer close to $7.3 bln takeover of weight loss drugmaker Metsera- FT  Investing.com

Dividend Paying Stocks With Strong Yields: Pfizer’s (PFE) Appeal Explained - Yahoo Finance

Dividend Paying Stocks With Strong Yields: Pfizer’s (PFE) Appeal Explained  Yahoo Finance

Pfizer Inc. $PFE Shares Sold by Palacios Wealth Management LLC - MarketBeat

Pfizer Inc. $PFE Shares Sold by Palacios Wealth Management LLC  MarketBeat

A Look at Pfizer’s (PFE) Valuation Following Fresh Legal Rulings and Positive COVID Vaccine Trial...

A Look at Pfizer’s (PFE) Valuation Following Fresh Legal Rulings and Positive COVID Vaccine Trial Data  Yahoo Finance

Neither Arvinas nor Pfizer now wants vepdegestrant | ApexOnco - Clinical Trials news and analysis...

Neither Arvinas nor Pfizer now wants vepdegestrant | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

Pfizer Stock Draws Focus On Report Of $7.3B Deal Plan For Metsera Buyout As Obesity Drug Race Wit...

Pfizer Stock Draws Focus On Report Of $7.3B Deal Plan For Metsera Buyout As Obesity Drug Race With Lilly, Novo Heats Up  MSN

Pfizer Inc. $PFE Shares Bought by HF Advisory Group LLC - MarketBeat

Pfizer Inc. $PFE Shares Bought by HF Advisory Group LLC  MarketBeat

Pfizer Stock Draws Focus On Report Of $7.3B Deal Plan For Metsera Buyout As Obesity Drug Race Wit...

Pfizer Stock Draws Focus On Report Of $7.3B Deal Plan For Metsera Buyout As Obesity Drug Race With Lilly, Novo Heats Up  Stocktwits

Pfizer Nears Potential $7.3 Billion Takeover of Metsera, FT Says - Bloomberg.com

Pfizer Nears Potential $7.3 Billion Takeover of Metsera, FT Says  Bloomberg.com

Fulton Bank N.A. Buys 19,852 Shares of Pfizer Inc. $PFE - MarketBeat

Fulton Bank N.A. Buys 19,852 Shares of Pfizer Inc. $PFE  MarketBeat

IFM Investors Pty Ltd Buys 41,263 Shares of Pfizer Inc. $PFE - MarketBeat

IFM Investors Pty Ltd Buys 41,263 Shares of Pfizer Inc. $PFE  MarketBeat

Wealth Enhancement Advisory Services LLC Boosts Holdings in Pfizer Inc. $PFE - MarketBeat

Wealth Enhancement Advisory Services LLC Boosts Holdings in Pfizer Inc. $PFE  MarketBeat

Procyon Advisors LLC Sells 19,895 Shares of Pfizer Inc. $PFE - MarketBeat

Procyon Advisors LLC Sells 19,895 Shares of Pfizer Inc. $PFE  MarketBeat

Pfizer (NYSE:PFE) Rating Increased to Buy at Wall Street Zen - MarketBeat

Pfizer (NYSE:PFE) Rating Increased to Buy at Wall Street Zen  MarketBeat

Swedbank AB Increases Stake in Pfizer Inc. $PFE - MarketBeat

Swedbank AB Increases Stake in Pfizer Inc. $PFE  MarketBeat

Mn Services Vermogensbeheer B.V. Boosts Stake in Pfizer Inc. $PFE - MarketBeat

Mn Services Vermogensbeheer B.V. Boosts Stake in Pfizer Inc. $PFE  MarketBeat

Pfizer Inc. $PFE Stake Boosted by Baader Bank Aktiengesellschaft - MarketBeat

Pfizer Inc. $PFE Stake Boosted by Baader Bank Aktiengesellschaft  MarketBeat

CX Institutional Buys 15,797 Shares of Pfizer Inc. $PFE - MarketBeat

CX Institutional Buys 15,797 Shares of Pfizer Inc. $PFE  MarketBeat

Redhawk Wealth Advisors Inc. Invests $1.15 Million in Pfizer Inc. $PFE - MarketBeat

Redhawk Wealth Advisors Inc. Invests $1.15 Million in Pfizer Inc. $PFE  MarketBeat

Pallas Capital Advisors LLC Sells 19,055 Shares of Pfizer Inc. $PFE - MarketBeat

Pallas Capital Advisors LLC Sells 19,055 Shares of Pfizer Inc. $PFE  MarketBeat

Exchange Traded Concepts LLC Buys 607,732 Shares of Pfizer Inc. $PFE - MarketBeat

Exchange Traded Concepts LLC Buys 607,732 Shares of Pfizer Inc. $PFE  MarketBeat

Cypress Point Wealth Management LLC Buys Shares of 11,714 Pfizer Inc. $PFE - MarketBeat

Cypress Point Wealth Management LLC Buys Shares of 11,714 Pfizer Inc. $PFE  MarketBeat

Sumitomo Mitsui DS Asset Management Company Ltd Acquires 27,043 Shares of Pfizer Inc. $PFE - Mark...

Sumitomo Mitsui DS Asset Management Company Ltd Acquires 27,043 Shares of Pfizer Inc. $PFE  MarketBeat

Arvinas, Pfizer to grant commercial rights of experimental breast cancer drug to third party - Re...

Arvinas, Pfizer to grant commercial rights of experimental breast cancer drug to third party  Reuters

Pfizer nears billion-dollar acquisition of anti-obesity drugmaker Metsera - medwatch.com

Pfizer nears billion-dollar acquisition of anti-obesity drugmaker Metsera  medwatch.com

Guggenheim Remains Bullish on Pfizer (PFE) - Yahoo Finance

Guggenheim Remains Bullish on Pfizer (PFE)  Yahoo Finance

Pfizer Nears $7.3 Billion Metsera Deal, FT Says, Citing Sources - MarketScreener

Pfizer Nears $7.3 Billion Metsera Deal, FT Says, Citing Sources  MarketScreener

Pfizer, Arvinas lose interest in commercializing PROTAC inhibitor, leading to layoffs at the biot...

Pfizer, Arvinas lose interest in commercializing PROTAC inhibitor, leading to layoffs at the biotech  Fierce Biotech

Pfizer (PFE) Nears $7.3 Billion Acquisition of Weight Loss Drug Developer Metsera - GuruFocus

Pfizer (PFE) Nears $7.3 Billion Acquisition of Weight Loss Drug Developer Metsera  GuruFocus

Should Pfizer’s (PFE) Antitrust Settlement and R&D Push Shift Investor Focus on Long-Term Risks? ...

Should Pfizer’s (PFE) Antitrust Settlement and R&D Push Shift Investor Focus on Long-Term Risks?  simplywall.st

Pfizer (PFE) Eyes $7.3 Billion Acquisition of Metsera (MTSR) - GuruFocus

Pfizer (PFE) Eyes $7.3 Billion Acquisition of Metsera (MTSR)  GuruFocus

Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports - Trading...

Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports  TradingView

Pfizer closes in on $7.3bn takeover of anti-obesity drugmaker Metsera - FT - MarketScreener

Pfizer closes in on $7.3bn takeover of anti-obesity drugmaker Metsera - FT  MarketScreener

Pfizer Nears $7.3 Billion Acquisition of Weight Loss Drug Develo - GuruFocus

Pfizer Nears $7.3 Billion Acquisition of Weight Loss Drug Develo  GuruFocus

Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports - Trading...

Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports  TradingView

Roivant reports phase 3 autoimmune win for ex-Pfizer asset - Fierce Biotech

Roivant reports phase 3 autoimmune win for ex-Pfizer asset  Fierce Biotech

Pfizer nears $7.3b takeover of US drug developer Metsera: report - Tech in Asia

Pfizer nears $7.3b takeover of US drug developer Metsera: report  Tech in Asia

Pfizer: Dividend Cushion Ratio Brings Yield Sustainability Into Question (NYSE:PFE) - Seeking Alpha

Pfizer: Dividend Cushion Ratio Brings Yield Sustainability Into Question (NYSE:PFE)  Seeking Alpha

Submissions open for Pfizer Independent Medical Education Grant (US) - fundsforNGOs

Submissions open for Pfizer Independent Medical Education Grant (US)  fundsforNGOs

Roivant, Pfizer’s Therapy Shows ‘Patient-Centered Benefit’ in Rare Inflammatory Condition - BioSpace

Roivant, Pfizer’s Therapy Shows ‘Patient-Centered Benefit’ in Rare Inflammatory Condition  BioSpace

Precision Trading with Pfizer Inc. (PFE) Risk Zones - news.stocktradersdaily.com

Precision Trading with Pfizer Inc. (PFE) Risk Zones  news.stocktradersdaily.com

Pfizer: Cheap Doesn't Mean Good (NYSE:PFE) - Seeking Alpha

Pfizer: Cheap Doesn't Mean Good (NYSE:PFE)  Seeking Alpha

8 things physicians and patients need to know about the Pfizer vaccine - American Medical Associa...

8 things physicians and patients need to know about the Pfizer vaccine  American Medical Association

Sowell Financial Services LLC Increases Stock Position in Pfizer Inc. $PFE - MarketBeat

Sowell Financial Services LLC Increases Stock Position in Pfizer Inc. $PFE  MarketBeat

Epilepsy Drugs Market to Witness Massive Growth by 2032 | Pfizer Inc. and Sumitomo Pharma Co., Lt...

Epilepsy Drugs Market to Witness Massive Growth by 2032 | Pfizer Inc. and Sumitomo Pharma Co., Ltd.  openPR.com

3 Things You Need to Know If You Buy Pfizer Today - The Motley Fool

3 Things You Need to Know If You Buy Pfizer Today  The Motley Fool

Pfizer, Arvinas to sell rights to lead PROTAC one month after filing for FDA review - Endpoints News

Pfizer, Arvinas to sell rights to lead PROTAC one month after filing for FDA review  Endpoints News

Assessing Pfizer Shares After Trump Officials Link COVID Vaccines to Child Deaths - Yahoo Finance

Assessing Pfizer Shares After Trump Officials Link COVID Vaccines to Child Deaths  Yahoo Finance

Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Val...

Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation  GlobeNewswire

Pfizer’s SWOT analysis: stock faces patent cliff as oncology push drives growth - Investing.com

Pfizer’s SWOT analysis: stock faces patent cliff as oncology push drives growth  Investing.com

Amid investor pressures, Arvinas to cut 15% of staff as it reshapes drug strategy with Pfizer - H...

Amid investor pressures, Arvinas to cut 15% of staff as it reshapes drug strategy with Pfizer  Hartford Business Journal

D&D Pharmatech surges to record high after Pfizer-Metsera takeover reports - CHOSUNBIZ - Chosun Biz

D&D Pharmatech surges to record high after Pfizer-Metsera takeover reports - CHOSUNBIZ  Chosun Biz

Pfizer, Arvinas change course on vepdegestrant despite recent FDA filing - FirstWord Pharma

Pfizer, Arvinas change course on vepdegestrant despite recent FDA filing  FirstWord Pharma

1 Reason Every Investor Should Know About Pfizer (PFE) Stock - Yahoo Finance

1 Reason Every Investor Should Know About Pfizer (PFE) Stock  Yahoo Finance

Pfizer says it couldn't have warned about tumor risk in Depo-Provera lawsuits - Reuters

Pfizer says it couldn't have warned about tumor risk in Depo-Provera lawsuits  Reuters

UMB Bank n.a. Reduces Position in Pfizer Inc. $PFE - MarketBeat

UMB Bank n.a. Reduces Position in Pfizer Inc. $PFE  MarketBeat

Pfizer Futures Internship Program Recognized as Top 100 in U.S. - Pfizer

Pfizer Futures Internship Program Recognized as Top 100 in U.S.  Pfizer

Science Drives Everything - Pfizer

Science Drives Everything  Pfizer

OLD Republic International Corp Raises Position in Pfizer Inc. $PFE - MarketBeat

OLD Republic International Corp Raises Position in Pfizer Inc. $PFE  MarketBeat

Arvinas stock price target lowered to $14 at Stephens on Pfizer partnership update - Investing.com

Arvinas stock price target lowered to $14 at Stephens on Pfizer partnership update  Investing.com

Pfizer eyes $7.3bn takeover of weight-loss drug developer Metsera - MSN

Pfizer eyes $7.3bn takeover of weight-loss drug developer Metsera  MSN

Pfizer close to acquiring Metsera for $7.3B, targeting breakthrough obesity drug - Invezz

Pfizer close to acquiring Metsera for $7.3B, targeting breakthrough obesity drug  Invezz

Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots ...

Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots  CNBC

FT: Pfizer nears US$7.3b takeover of weight-loss drugmaker Metsera - Malay Mail

FT: Pfizer nears US$7.3b takeover of weight-loss drugmaker Metsera  Malay Mail

Arvinas, Pfizer to outlicense commercialization of cancer asset vepdegestrant - Seeking Alpha

Arvinas, Pfizer to outlicense commercialization of cancer asset vepdegestrant  Seeking Alpha

Sarasin & Partners LLP Has $35.26 Million Stake in Pfizer Inc. $PFE - MarketBeat

Sarasin & Partners LLP Has $35.26 Million Stake in Pfizer Inc. $PFE  MarketBeat

Arvinas amends collaboration with Pfizer - The Pharma Letter

Arvinas amends collaboration with Pfizer  The Pharma Letter

Grant Private Wealth Management Inc Purchases New Shares in Pfizer Inc. $PFE - MarketBeat

Grant Private Wealth Management Inc Purchases New Shares in Pfizer Inc. $PFE  MarketBeat

Pfizer Inc. $PFE Shares Sold by Busey Bank - MarketBeat

Pfizer Inc. $PFE Shares Sold by Busey Bank  MarketBeat

Kingstone Capital Partners Texas LLC Invests $30.34 Million in Pfizer Inc. $PFE - MarketBeat

Kingstone Capital Partners Texas LLC Invests $30.34 Million in Pfizer Inc. $PFE  MarketBeat

Pfizer, Moderna post data supporting COVID shots after Trump demand - Seeking Alpha

Pfizer, Moderna post data supporting COVID shots after Trump demand  Seeking Alpha

Fulton Bank N.A. Buys 19,852 Shares of Pfizer Inc. $PFE - InsuranceNewsNet

Fulton Bank N.A. Buys 19,852 Shares of Pfizer Inc. $PFE  InsuranceNewsNet

Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera: Report - The Economi...

Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera: Report  The Economic Times

Conflicts of Interest Disclosures of ACIP Members - Centers for Disease Control and Prevention | ...

Conflicts of Interest Disclosures of ACIP Members  Centers for Disease Control and Prevention | CDC (.gov)

Pfizer’s BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600...

Pfizer’s BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer  Pfizer

Pharma company Pfizer to cut up to 58 jobs at headquarters in Brussels - belganewsagency.eu

Pharma company Pfizer to cut up to 58 jobs at headquarters in Brussels  belganewsagency.eu

Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual Meeting - Pfizer

Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual Meeting  Pfizer

My Legacy Advisors LLC Grows Position in Pfizer Inc. $PFE - MarketBeat

My Legacy Advisors LLC Grows Position in Pfizer Inc. $PFE  MarketBeat

Pfizer's Strategic Move: Potential $7.3 Billion Acquisition of Metsera Set to Shake Up Weight-Los...

Pfizer's Strategic Move: Potential $7.3 Billion Acquisition of Metsera Set to Shake Up Weight-Loss Drug Market  Devdiscourse

SeaCrest Wealth Management LLC Purchases 18,226 Shares of Pfizer Inc. $PFE - MarketBeat

SeaCrest Wealth Management LLC Purchases 18,226 Shares of Pfizer Inc. $PFE  MarketBeat

Pfizer Eyes Major Merger in Anti-Obesity Sector Amid Rising Health Concerns - Devdiscourse

Pfizer Eyes Major Merger in Anti-Obesity Sector Amid Rising Health Concerns  Devdiscourse

Pfizer Inc. $PFE Shares Acquired by Wedge Capital Management L L P NC - MarketBeat

Pfizer Inc. $PFE Shares Acquired by Wedge Capital Management L L P NC  MarketBeat

NBC Securities Inc. Sells 16,191 Shares of Pfizer Inc. $PFE - MarketBeat

NBC Securities Inc. Sells 16,191 Shares of Pfizer Inc. $PFE  MarketBeat

Pfizer Eyes $7.3 Billion Acquisition of Metsera - Devdiscourse

Pfizer Eyes $7.3 Billion Acquisition of Metsera  Devdiscourse

Pfizer Eyes $7.3 Billion Acquisition of Metsera in Weight-Loss Drug Market Sweep - Devdiscourse

Pfizer Eyes $7.3 Billion Acquisition of Metsera in Weight-Loss Drug Market Sweep  Devdiscourse

Pfizer, Novartis, BMS, Lilly and others targeted in FDA’s TV ad crackdown - Endpoints News

Pfizer, Novartis, BMS, Lilly and others targeted in FDA’s TV ad crackdown  Endpoints News

Mirador Capital Partners LP Has $1.18 Million Stake in Pfizer Inc. $PFE - MarketBeat

Mirador Capital Partners LP Has $1.18 Million Stake in Pfizer Inc. $PFE  MarketBeat

Pfizer Inc. $PFE Stock Position Increased by Czech National Bank - MarketBeat

Pfizer Inc. $PFE Stock Position Increased by Czech National Bank  MarketBeat

Gateway Investment Advisers LLC Grows Stock Position in Pfizer Inc. $PFE - MarketBeat

Gateway Investment Advisers LLC Grows Stock Position in Pfizer Inc. $PFE  MarketBeat

Arvinas and Pfizer to out-license breast cancer drug vepdegestrant - Investing.com

Arvinas and Pfizer to out-license breast cancer drug vepdegestrant  Investing.com

Beacon Financial Group Has $3.23 Million Stock Holdings in Pfizer Inc. $PFE - MarketBeat

Beacon Financial Group Has $3.23 Million Stock Holdings in Pfizer Inc. $PFE  MarketBeat

Martin Capital Partners LLC Has $4.62 Million Position in Pfizer Inc. $PFE - MarketBeat

Martin Capital Partners LLC Has $4.62 Million Position in Pfizer Inc. $PFE  MarketBeat

Pfizer Launches “Power of Knowing” Video Series with Chief Digital and Technology Officer - Pfizer

Pfizer Launches “Power of Knowing” Video Series with Chief Digital and Technology Officer  Pfizer

Pfizer (NYSE:PFE) Shares Unloaded Rep. Gilbert Ray Cisneros, Jr. - MarketBeat

Pfizer (NYSE:PFE) Shares Unloaded Rep. Gilbert Ray Cisneros, Jr.  MarketBeat

Astellas and Pfizer’s XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormo...

Astellas and Pfizer’s XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer  Pfizer